Latest Statin Stories
First Positive Regulatory Agency Determination for a PCSK9 Inhibitor THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal
Bernstein Liebhard is representing federal Lipitor lawsuit plaintiffs, all of whom allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin medication.
Study not only confirms results from first human study but also shows even stronger effect of a KAMUT® khorasan wheat based diet in blood markers of patients suffering from ACS, especially
Bernstein Liebhard LLP is representing plaintiffs in federal Lipitor lawsuits that accuse Pfizer, Inc.
Both Standard and Aggressive Treatment Provide Similar Benefit in Reducing Atherosclerosis SAN DIEGO, May 7, 2015 /PRNewswire/ -- Treating both low-density lipoprotein (LDL), or "bad,"
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation, which involves thousands of cases alleging the statin medication increases a patient’s
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal multidistrict litigation who allege that Pfizer, Inc.
Bernstein Liebhard LLP is representing Lipitor lawsuit plaintiffs in the federal proceeding established in District of South Carolina for product liability claims alleging the statin medication
Bernstein Liebhard LLP is representing Lipitor Lawsuit plaintiffs in the federal proceeding, which involves allegations that the statin medication caused patients to develop new-onset Type 2 diabetes.
Bernstein Liebhard LLP is representing clients who have filed Lipitor lawsuits in the federal multidistrict litigation. New York, New York (PRWEB) March 31,
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).